Immune checkpoint inhibitor therapy and outcomes from sars-cov-2 infection in patients with cancer: a joint analysis of oncovid and esmo-cocare registries

HIGHLIGHTS

• who: Alessio Cortellini u200d u200d et al. from the OnCovid (NCT04393974) is a European registry study approved by the UK have published the research: Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries, in the Journal: (JOURNAL) of December/14,/2021
• what: Although preliminary evidence from clinical trials supports the safety and immunogenicity of SARS-u00adCoV-u00ad2 vaccines in patients with cancer on active ICI-u00ad based treatments 29 30 this study shows the efficacy of anti-u00adCOVID-u00ad19 vaccination . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.